US FDA approves Abbott’s more potent testosterone gel
This article was originally published in Scrip
Executive Summary
The US FDA approved a higher concentration of Abbott's testosterone gel as a therapy for men with hypogonadism, or low testosterone, a condition associated with erectile dysfunction and decreased sexual desire, fatigue and loss of energy, depressed mood, osteoporosis and a diminishment in the physical characteristics of a man, such as decreased body hair.